\BOOKMARK [0][]{chapter*.1}{Contents}{}% 1
\BOOKMARK [0][]{chapter*.2}{List of Figures}{}% 2
\BOOKMARK [0][]{chapter*.3}{List of Tables}{}% 3
\BOOKMARK [0][]{chapter.1}{1 Lung Cancer}{}% 4
\BOOKMARK [1][]{section.1.1}{1.1 See Steven's email 22/10/15}{chapter.1}% 5
\BOOKMARK [1][]{section.1.2}{1.2 Epidemiology}{chapter.1}% 6
\BOOKMARK [1][]{section.1.3}{1.3 Aetiology}{chapter.1}% 7
\BOOKMARK [1][]{section.1.4}{1.4 Histopathology}{chapter.1}% 8
\BOOKMARK [1][]{section.1.5}{1.5 Mutation}{chapter.1}% 9
\BOOKMARK [2][]{subsection.1.5.1}{1.5.1 EGFR}{section.1.5}% 10
\BOOKMARK [2][]{subsection.1.5.2}{1.5.2 KRAS}{section.1.5}% 11
\BOOKMARK [2][]{subsection.1.5.3}{1.5.3 ALK / ROS1 Rearrnagment}{section.1.5}% 12
\BOOKMARK [1][]{section.1.6}{1.6 Prognosis}{chapter.1}% 13
\BOOKMARK [2][]{subsection.1.6.1}{1.6.1 Early Stage}{section.1.6}% 14
\BOOKMARK [2][]{subsection.1.6.2}{1.6.2 Late Stage}{section.1.6}% 15
\BOOKMARK [1][]{section.1.7}{1.7 Diagnosis}{chapter.1}% 16
\BOOKMARK [2][]{subsection.1.7.1}{1.7.1 Radiology}{section.1.7}% 17
\BOOKMARK [2][]{subsection.1.7.2}{1.7.2 Tissue Obtaining}{section.1.7}% 18
\BOOKMARK [1][]{section.1.8}{1.8 Tissue analysis}{chapter.1}% 19
\BOOKMARK [2][]{subsection.1.8.1}{1.8.1 current methods}{section.1.8}% 20
\BOOKMARK [2][]{subsection.1.8.2}{1.8.2 next gen sequencing}{section.1.8}% 21
\BOOKMARK [0][]{subsection.1.8.2}{Bibliography}{}% 22
